Incyte CMO receives equity awards, sells 1,877 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Steven H. Stein, Incyte's CMO and Head of Late-Stage Development, reported July 16, 2026 equity activity including grants of 9,798 restricted stock units, 24,496 performance shares, and 42,298 stock options with an exercise price of 116.6500 per share, plus a sale of 1,877 common shares at 114.7300 per share. These transactions were made under a Rule 10b5-1 trading plan. The RSUs vest 25% annually over four years, the options vest over four years in 37 installments, and performance shares may earn up to 200% of one share based on three-year relative TSR versus a peer group.
Insider Trade Summary 10b5-1
Net Seller: 1,877 shares
Net Sell
4 txns
Insider
Stein Steven H
Role
CMO & Head of Late-Stage Dev.
Sold
1,877 shs ($215K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Shares F3 | 24,496 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) F4 | 42,298 | $0.00 | $0.00 |
| Sale | Common Stock | 1,877 | $114.73 | $215K |
| Grant/Award | Common Stock F1, F2 | 9,798 | $0.00 | $0.00 |
Holdings After Transaction:
Performance Shares — 24,496 contracts (Direct);
Employee Stock Option (right to buy) — 42,298 contracts (Direct);
Common Stock — 30,916 shares (Direct)
Footnotes (4)
- F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- F2. Including the July 16, 2026 grant, this includes an aggregate of 29,338 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
- F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:
Key Figures
RSUs granted: 9,798 shares
Performance shares granted: 24,496 performance shares
Stock options granted: 42,298 options
+5 more
8 metrics
RSUs granted
9,798 shares
Restricted stock units granted to Steven H. Stein on July 16, 2026
Performance shares granted
24,496 performance shares
Performance share award to Stein on July 16, 2026
Stock options granted
42,298 options
Employee stock options granted to Stein on July 16, 2026
Option exercise price
116.6500 per share
Exercise price for the 42,298 options granted to Stein
Common shares sold
1,877 shares
Sale of Incyte common stock by Stein on July 16, 2026
Sale price per share
114.7300 per share
Price received per share in Stein's 1,877-share sale
Unvested RSUs and performance units
29,338 shares
Aggregate shares issuable from Stein's unvested RSUs and earned performance units
Performance share maximum payout
200%
Each performance share may earn up to 200% of one share of common stock
Key Terms
restricted stock units ("RSUs"), performance share, relative total shareholder return ("TSR"), Performance Share Award Agreement
4 terms
restricted stock units ("RSUs") financial
"Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What new equity awards did Incyte (INCY) grant to CMO Steven H. Stein?
Steven H. Stein received 9,798 RSUs, 24,496 performance shares and 42,298 stock options on July 16, 2026. The RSUs vest 25% annually over four years, while the options vest over four years in 37 installments tied to continued service.
What are the vesting terms for the RSUs granted to Incyte (INCY) CMO Stein?
The 9,798 restricted stock units vest 25% annually over four years. Each RSU may be settled only for one share of common stock on a one-for-one basis, providing time-based equity compensation linked to Stein's continued employment with Incyte.
What unvested equity does Steven H. Stein hold after the July 16, 2026 grants at INCY?
Including the July 16, 2026 RSU grant, Stein holds an aggregate of 29,338 shares of common stock issuable from previously reported RSUs and earned performance stock units that have not yet vested, representing his outstanding time- and performance-based equity awards.
Were Steven H. Stein's July 16, 2026 transactions in INCY under a trading plan?
The disclosure affirms a Rule 10b5-1 trading plan for these transactions. That means Stein's equity grants and the 1,877-share sale were executed according to pre-arranged instructions, reducing the role of discretionary timing in the reported activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates